investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Disease: Neurology/Alzheimer/Parkinson's ↓1.21   Biopharma ↓0.55   Immunology 0.00 «See more»   Disease: Metabolic disorders ↑2.56   Respiratory therapies / Pulmanory ↑2.56   Biotechnology ↑11.48

Disease: Central nervous system (CNS) stock segment: trending tickers

CYCN Cyclerion Therapeutics, Inc. - Common Stock 3.17% 3.17% 0 + Medicine, Disease: Central nervous system (CNS)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1755237/000119312525142765/0001193125-25-142765-index.htm
8-K - Cyclerion Therapeutics, Inc. (0001755237) (Filer)
+ My List
PRAX Praxis Precision Medicines, Inc. - Common Stock -1.31% -1.31% 0 + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1689548/000168954825000075/0001689548-25-000075-index.htm
8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer)
+ My List
RLMD Relmada Therapeutics, Inc. - Common Stock 11.48% 11.48% 0 + Disease: Central nervous system (CNS), Biotechnology, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1553643/000121390025062803/0001213900-25-062803-index.htm
8-K - RELMADA THERAPEUTICS, INC. (0001553643) (Filer)
+ My List
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock 0.00% 0 + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1430306/000199937125008900/0001999371-25-008900-index.htm
8-K - Tonix Pharmaceuticals Holding Corp. (0001430306) (Filer)
+ My List
TSHA Taysha Gene Therapies, Inc. - Common Stock 4.31% up 2.75% 1.56 + Gene and cell, Disease: Central nervous system (CNS), Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1806310/000119312525133745/0001193125-25-133745-index.htm
8-K - Taysha Gene Therapies, Inc. (0001806310) (Filer)
+ My List
TTNP Titan Pharmaceuticals, Inc. - Common Stock -1.58% -1.58% 0 + Biopharma, Disease: Central nervous system (CNS), Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/910267/000182912625004764/0001829126-25-004764-index.htm
8-K - TITAN PHARMACEUTICALS INC (0000910267) (Filer)
+ My List
VTGN VistaGen Therapeutics, Inc. - Common Stock -3.21% -3.21% 0 + Medicine, Disease: Central nervous system (CNS)

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1411685/000141168525000048/0001411685-25-000048-index.htm
8-K - Vistagen Therapeutics, Inc. (0001411685) (Filer)
+ My List
RVPH Reviva Pharmaceuticals Holdings, Inc. - Common Stock 2.56% 2.56% 0 + Medicine, Biopharma, Pharmaceutical , Disease: Metabolic disorders, Disease: Central nervous system (CNS), Respiratory therapies / Pulmanory

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1742927/000143774925021361/0001437749-25-021361-index.htm
8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. (0001742927) (Filer)
+ My List
DRUG Bright Minds Biosciences Inc. - common stock -2.41% -2.41% 0 + Disease: Central nervous system (CNS), Biopharma, Medicine, Disease: Neurology/Alzheimer/Parkinson's

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1827401/000118374025000037/0001183740-25-000037-index.htm
6-K - BRIGHT MINDS BIOSCIENCES INC. (0001827401) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.